Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRA-1: MR Prednisone vs Standard Prednisone in RA
NCT00146640Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Aug 2004
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of prednisone in rheumatoid arthritis (RA) (2 arms), sponsored by Merck KGaA. Primary endpoint: Relative Change From Baseline in Duration of Morning Stiffness at 12 weeks. Started Aug 2004; status: completed.
02
Drugs
prednisone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00146640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146640.